More than half of all patients do not remember their physicians’ recommendations and treatments unless prompted.
One hospital or office visit can leave patients with a lot of information to process, including diagnoses, treatment decisions, prescriptions, instructions for care, and critical steps that must be taken in between visits. Following the appointment, patients may feel overwhelmed or unable to remember what needs to be done. More than half of all patients do not remember their physicians’ recommendations and treatments unless prompted.1
Clinicians must wait until they see the patient again weeks or months later, leaving them with a blind spot in disease management and potential medical issues. These blind spots can lead to poorer health outcomes, particularly when worsening symptoms are not quickly addressed. Patients need to be able to identify symptoms, manage medications and/ or equipment, and know when to call the clinician or go to the hospital.
Digital health advances make it easier for patients to self-monitor, manage medications, and share information with clinicians. When patients use technology to track and share their health data between visits, clinicians have the insights they need to manage and better understand the patient’s care journey so they can help improve outcomes and experiences. Self-monitoring and data sharing also result in significant reductions in hospitalization and hospital readmissions, reducing the burden on emergency care services.2
Technology can be used to track patient conditions, prompt patients to record timely health measures, and share these data with their clinician. Communication is vital to effective care. If patients are diagnosed early and adhere to treatments, they have better outcomes. If patients and clinicians have a better connection and more opportunity to communicate, patients are more likely to participate actively in their care and better understand how to manage outcomes. The easier it is for patients to report their information to their clinicians’ systems, the faster we can achieve better outcomes and experiences that affect the entire health care system.
Kota Kubo is cofounder and co-CEO of Ubie. For full article and more information, visit https://bit.ly/3xw3DaB
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers
December 20th 2024During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.
Read More
Participants Discuss Frontline Immunotherapy Followed by ADC for Metastatic Cervical Cancer
December 19th 2024During a Case-Based Roundtable® event, Ramez N. Eskander, MD, and participants discussed first and second-line therapy decisions for a patient with PD-L1–positive cervical cancer in the frontline metastatic setting.
Read More
Oncologists Discuss a Second-Generation BTK for Relapsed/Refractory CLL
December 18th 2024During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed chronic lymphocytic leukemia after receiving venetoclax and obinutuzumab.
Read More